ArticleHPB : the official journal of the International Hepato Pancreato Biliary Association2005
Liver cell adenoma and liver cell adenomatosis.
Article in HPB : the official journal of the International Hepato Pancreato Biliary Association, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.
- Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases.HPB : the official journal of the International Hepato Pancreato Biliary Association · 2010Pooled it
- Nonoperative Management of Hepatic Adenomas: A Review.Journal of gastrointestinal cancer · 2026Review
- Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypes.European radiology · 2025Article
- Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture.Diagnostics (Basel, Switzerland) · 2024Article
- Case Report: Hepatic Adenomatosis in a Patient With Prader-Willi Syndrome.Frontiers in endocrinology · 2022Article
- HBP-enhancing hepatocellular adenomas and how to discriminate them from FNH in Gd-EOB MRI.BMC medical imaging · 2021Article
- Unclassified hepatocellular adenoma with beta-catenin mutation: a case report.Surgical case reports · 2021Article
- Hepatic Adenomatosis in a Young Asymptomatic but High-risk Patient: An Incidental Diagnosis with Potentially Severe Clinical Implications.European journal of case reports in internal medicine · 2021Article
- Article
- A rare case of hepatocellular carcinoma arising from gadoxetate-retaining hepatic adenoma.Radiology case reports · 2020Article
- Safety and efficacy of transarterial embolization of hepatocellular adenomas.The British journal of surgery · 2019Article
- Case of resected multiple hepatocellular adenomas in a young man with severe obesity.Surgical case reports · 2019Article
- Malignant transformation of hepatocellular adenoma in a young female patient after ovulation induction fertility treatment: A case report.World journal of gastrointestinal surgery · 2019Article
- Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency.Case reports in hepatology · 2019Article
- Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlation.Clinical radiology · 2018Article
- Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing.PloS one · 2018Article
- Indications for liver surgery in benign tumours.European surgery : ACA : Acta chirurgica Austriaca · 2018Article
- Short-term outcomes of laparoscopic vs. open liver resection for hepatocellular adenoma: a multicenter propensity score adjustment analysis by the AFC-HCA-2013 study group.Surgical endoscopy · 2017Article
- 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report.World journal of hepatology · 2017Article
- Hepatocellular adenoma: when and how to treat? Update of current evidence.Therapeutic advances in gastroenterology · 2016Review
Corrections and comments
- Commented on by
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the last three decades liver cell adenoma and liver cell adenomatosis have emerged as new clinical entities in hepato-logical practice due to the widespread use of oral contraceptives and increased imaging of the liver. On review of published series there is evidence that 10% of liver cell adenomas progress to hepatocellular carcinoma, diagnosis is best made by open or laparoscopic excision biopsy, and the preferred treatment modality is resection of the liver cell adenoma to prevent bleeding and malignant transformation. In liver cell adenomatosis, the association with oral contraceptive use is not as high as in solitary liver cell adenomas. The risk of malignant transformation is not increased compared with solitary liver cell adenomas. Treatment consists of close monitoring and imaging, resection of superficially located, large (>4 cm) or growing liver cell adenomas. Liver transplantation is the last resort in case of substantive concern about malignant transformation or for large, painful adenomas in liver cell adenomatosis after treatment attempts by liver resection.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.